TIAA CREF INVESTMENT MANAGEMENT LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 207 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2019. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q1 2019$4,854,000
+31.2%
91,715
+1.7%
0.00%0.0%
Q4 2018$3,701,000
-48.2%
90,152
-52.0%
0.00%
+50.0%
Q3 2018$7,140,000
+54.2%
187,904
+83.4%
0.00%
-33.3%
Q2 2018$4,630,000
+3.2%
102,429
+10.3%
0.00%0.0%
Q1 2018$4,485,000
+26.5%
92,862
+3.1%
0.00%
+50.0%
Q4 2017$3,546,000
-9.4%
90,111
-28.5%
0.00%
-33.3%
Q3 2017$3,915,000
-43.9%
126,073
-50.6%
0.00%
-40.0%
Q2 2017$6,975,000
+44.9%
255,045
+95.3%
0.01%
+66.7%
Q1 2017$4,813,000
+258.4%
130,606
+40.5%
0.00%
+200.0%
Q4 2016$1,343,000
-7.0%
92,934
+48.3%
0.00%0.0%
Q3 2016$1,444,000
+94.3%
62,651
+40.0%
0.00%0.0%
Q2 2016$743,000
+112.9%
44,761
+103.3%
0.00%
Q1 2016$349,000
-65.6%
22,013
-29.9%
0.00%
-100.0%
Q4 2015$1,016,000
+16.9%
31,415
+52.5%
0.00%0.0%
Q3 2015$869,00020,6050.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q1 2019
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders